News

Coronavirus (COVID-19): Legal Resources

Arnold & Porter has established a multidisciplinary Coronavirus Task Force with the crisis management, regulatory, litigation and transactional expertise necessary to plan for and navigate the legal and public policy impact of this pandemic. Our Task Force combines the experience of former senior government officials with the expertise of highly ranked practitioners across the US, Asia and Europe.

» Meet Our Task Force Members

» Explore Our Resource Guides

Advisories and Webinars

Resources

2020 CARES Act: FAQs for Nonprofits

Policymaker Speaker Series

CARES Act Fraud Tracker

DC-area Real Estate Update
May 8, 2020

COVID-19 Environmental Enforcement Update

Explore Arnold & Porter's Blogs

Perspectives

Banking & Finance Biweekly Update: Banking Agency Enforcement and Its Impact on Parallel DOJ Investigations
Coronavirus: Financial Services Webinar
EPA Eyes Long-Lasting Disinfectants as Next Step in Fight Against COVID-19
Coronavirus: Environmental Advisory
Banking & Finance Biweekly Update: What's Left on the Regulatory Agenda? Open Financial Regulatory Reform Items for the Trump Administration
Coronavirus: Financial Services Webinar
The world needs a coordinated Covid policy—based on social realities, not just 'the science'
City A.M.
Banking & Finance Biweekly Update: Bank M&A in a Prolonged COVID-19 World
Coronavirus: Financial Services Webinar
Banking & Finance Biweekly Update: AML Developments During the COVID-19 Crisis
Coronavirus: Financial Services Webinar
Policymaker Speaker Series: Featuring US Senator Michael Bennet (D-CO)
Arnold & Porter Webinar
Virginia Companies Must Know The Limits Of COVID-19 Liability Waivers
Hospitality Law360, Personal Injury & Medical Malpractice Law360, Public Policy Law360, Retail & E-Commerce Law360
Policymaker Speaker Series: Featuring Assemblymember Rebecca Bauer-Kahan (D-CA)
Arnold & Porter Webinar
Global Construction Forum: Dealing With COVID-19 and Its Aftereffects
Coronavirus: International Arbitration and Commercial Litigation Webinar
Tracking Fraud, Waste and Abuse of COVID-19 Relief Funds
Enforcement Edge: Shining Light on Government Enforcement
Banking & Finance Developments During the COVID-19 Crisis—Biweekly Update
Coronavirus: Financial Services Webinar
Key FDA Drug Inspection Challenges Amid COVID-19
Compliance Law360, Life Sciences Law360, Public Policy Law360
Consultation on legislative changes to support the rollout of COVID-19 vaccines in the UK
BioSlice Blog
Banking & Finance Developments During the COVID-19 Crisis—Biweekly Update
Coronavirus: Financial Services Webinar
Three Things to Know About PPP Fair Lending Scrutiny
Coronavirus: Financial Services Advisory
Banking & Finance Developments During the COVID-19 Crisis—Biweekly Update
Coronavirus: Financial Services Webinar
US Attorneys Announce MOUs With Special Inspector General for Pandemic Recovery
Enforcement Edge: Shining Light on Government Enforcement
Update: Regulation for COVID-19 clinical trials conducted with medicinal products containing or consisting of GMOs has now been adopted
BioSlice Blog
Coronavirus Legislative Update: Senate Republicans Introduce the HEALS Act COVID-19 Response Legislative Package and Begin Negotiations to Bring a Final Bill to the President's Desk in the Coming Weeks
Coronavirus: Multipractice Advisory
CARES Act/Federal Reserve Act Section 13(3): Update 9
Coronavirus: Financial Services Webinar
Policymaker Speaker Series: Featuring US Representative Bob Latta (R-OH)
Arnold & Porter Webinar
Selling a COVID-19 "Cure"
Enforcement Edge: Shining Light on Government Enforcement
CFTC Jumps Into the Fray of COVID-19 Enforcement
Enforcement Edge: Shining Light on Government Enforcement
FDA Relaxes Certain Drug Sample Distribution Rules During COVID-19 Pandemic
Enforcement Edge: Shining Light on Government Enforcement
A Golden Ticket? White Collar Defendants Seek Home Confinement Under DOJ's COVID-19 Compassionate Release Guidelines
Enforcement Edge: Shining Light on Government Enforcement
The European Commission proposes a Regulation for COVID-19 clinical trials conducted with medicinal products containing or consisting of GMOs
BioSlice Blog
Money Laundering Risks in the Pandemic
Enforcement Edge: Shining Light on Government Enforcement
COVID-19 Management Strategy After the Lockdown: Legal Consequences of an Effective Liquidity and Personnel Planning
Coronavirus: Labor & Employment Advisory-Germany
Policymaker Speaker Series: Featuring US Senator Cory Booker (D-NJ)
Arnold & Porter Webinar
Arrayit Faces DOJ Prosecution for Alleged Securities and COVID-19-Related Healthcare Fraud
Enforcement Edge: Shining Light on Government Enforcement
The Price of Price Gouging During the COVID-19 Pandemic
Enforcement Edge: Shining Light on Government Enforcement
CARES Act/Federal Reserve Act Section 13(3): Update 8
Coronavirus: Financial Services Webinar
EU and UK Compliance Considerations in Remote Promotion Training and Medical Information Services
Coronavirus: Life Sciences & Healthcare Regulatory Webinar
Welcome to Enforcement Edge
Enforcement Edge: Shining Light on Government Enforcement
EPA Virus Policies Spur Controversy and Claims They Will Increase Risk
Environmental Law Institute (www.eli.org)
CARES Act/Federal Reserve Act Section 13(3): Weekly Update 7
Coronavirus: Financial Services Webinar
Pharmaceutical and Medical Device Global Supply Chains Under a Microscope: Understanding and Managing the Growing Risks
Coronavirus: Life Sciences and Healthcare Regulatory Webinar
Small Business Administration Releases New and Revised Loan Forgiveness Applications to Implement Terms of the Paycheck Protection Program Flexibility Act
Coronavirus: Financial Services Advisory
FCA Exposure in the Age of COVID—How to Distance Yourself From Liability
Coronavirus: False Claims Act Webinar
Recent EPA Enforcement Action Provides Wake-Up Call to Retailers of Products Making Misleading COVID-19 Claims
Coronavirus: Environmental Advisory
Re-Opening Your Business in a COVID Environment: A Discussion on Protecting Consumers and Employees
Coronavirus: Multipractice Webinar
Maximizing Recovery: Contractor Reimbursement for COVID-19 Paid Leave Under § 3610 of the CARES Act
The Government Contractor, Vol. 62, No. 22
University Preparedness for a Pandemic: Key Testing and Privacy Considerations Every University Should Be Aware Of
Coronavirus: Privacy and Data Security Advisory
EU Medical Devices Regulation: implementation progress during the pandemic
BioSlice Blog
Policymaker Speaker Series: Featuring US Representative Kurt Schrader (D-OR)
Coronavirus: Legislative and Public Policy Webinar
Policymaker Speaker Series: Featuring US Representative Don Beyer (D-VA)
Coronavirus: Legislative and Public Policy Webinar
Arnold & Porter Advises AstraZeneca in Global Funding, Development and Distribution of Potential COVID-19 Vaccine
FDA Inspection Alternatives During the COVID-19 Pandemic: Requesting, Preparing for, and Responding to an FDA Virtual Inspection
Coronavirus: Life Sciences and Healthcare Regulatory Webinar
Courts Delay Chapter 11 Tenants' Rent Payments Due to COVID-19
Coronavirus: Bankruptcy and Restructuring Advisory
Deep Dive into the Department of Defense Implementation of CARES Act Section 3610
Presenter, Federal Publications Seminars
CARES Act/Federal Reserve Act Section 13(3): Weekly Update 6
Coronavirus: Financial Services Webinar
PREP Act Declaration Amended to Clarify Coverage of Products Used to "Limit the Harm" From COVID-19
Coronavirus: Life Sciences & Healthcare Regulatory Advisory
Defense Department Signals Way Forward for Contractor Paid Leave Reimbursement Under CARES Act Section 3610
Coronavirus: Government Contracts Advisory
COVID-19 Contact-Tracing Apps: What Privacy Law Will Apply?
Coronavirus: Multipractice Advisory
State Department Announces Limited Opportunity to Comment on ITAR Compliance Relief Due to COVID-19
Coronavirus: Multipractice Advisory
Lender Involvement in PPP Fraud Investigations
Coronavirus: Financial Services Advisory
Term Asset-Backed Securities Loan Facility
Coronavirus: Financial Services Advisory
Paycheck Protection Program Flexibility Act
Coronavirus: Financial Services Advisory
CARES Act/Federal Reserve Act Section 13(3): Weekly Update 5
Coronavirus: Financial Services Webinar
Executive Order on Regulatory Relief Issued to Support Economic Recovery
Coronavirus: Multipractice Advisory
Policymaker Speaker Series: Featuring US Representative Michael C. Burgess, MD (R-TX)
Coronavirus: Legislative and Public Policy Webinar
DC Council's Comprehensive Response to COVID-19: Key Provisions for the Real Estate Community
Coronavirus: Real Estate Advisory
What Biopharmaceutical and Medical Device Companies Need to Know About Telemedicine and Patient Care
Arnold & Porter Webinar Series: Pharma 3.0
FDA Issues Guidance on New Medical Device Shortage Reporting Requirements
Coronavirus: Life Sciences and Healthcare Regulatory Advisory
Emergency Federal Financing Programs to Address the Economic Impact of the COVID-19 Pandemic
Coronavirus: Financial Services Advisory
Financial Services Regulatory Actions to Address the Economic Impact of the COVID-19 Pandemic
Coronavirus: Financial Services Advisory
CARES Act/Federal Reserve Act Section 13(3): Weekly Update 4
Coronavirus: Financial Services Webinar
Considerations for Acquisitions and Investments Involving Companies That Have Taken CARES Act Funding
Coronavirus: Corporate and Finance Advisory
Policymaker Speaker Series: Featuring US Representative Cathy McMorris Rodgers (R-WA)
Coronavirus: Legislative and Public Policy Webinar
Guidance for Borrowers on the Paycheck Protection Program Loan Forgiveness Application
Coronavirus: Multipractice Advisory
Guidance for Lenders on the Paycheck Protection Program Loan Forgiveness Application
Coronavirus: Multipractice Advisory
Policymaker Speaker Series: Featuring US Senator Jack Reed (D-RI)
Coronavirus: Legislative and Public Policy Webinar
CARES Act/Federal Reserve Act Section 13(3): Weekly Update 3
Coronavirus: Financial Services Webinar
Navigating COVID-19 Related Congressional Investigations
Coronavirius: Multiple Practice Webinar
Strategic National Stockpile 2.0: The Department of Health and Human Services Issues Request for Information Relating to the Strategic National Stockpile
Coronavirus: Multipractice Advisory
NYSE Provides Additional Relief from Its Shareholder Approval Requirements for Specified Private Placements Through June 30, 2020
Coronavirus: Corporate and Finance Advisory
Navigating Patient Needs Remotely: Addressing Challenges in Patient Access
Arnold & Porter Webinar Series: Pharma 3.0
Policymaker Speaker Series: Featuring US Representatives Joyce Beatty (D-OH) and Steve Stivers (R-OH)
Coronavirus: Legislative and Public Policy Webinar
A Guide to the Contract Disputes Act's Six Year Statute of Limitations
GCA Digest, Vol 21, No. 4
Understanding and Leveraging the Defense Production Act
Coronavirus: Government Contracts Webinar
CARES Act/Federal Reserve Act Section 13(3): Weekly Update 2
Coronavirus: Multipractice Webinar
HEROES IN THE HOUSE: Congress Begins Consideration of a 5th COVID-19 Response Package Totaling $3 Trillion in New Spending
Coronavirus: Legislative & Public Policy Advisory
FDA and Other Compliance Considerations in Remote Promotion, Training and Medical Information Services
Arnold & Porter Webinar Series: Pharma 3.0
Policymaker Speaker Series: Featuring US Senator Shelley Moore Capito (R-WV)
Coronavirus: Legislative and Public Policy Webinar
COVID-19: How German Employers Can Handle the Crisis and Prepare for a Return to Work
Coronavirus: Labor and Employment Advisory
Policymaker Speaker Series: Featuring US Senator Thom Tillis (R-NC)
Coronavirus: Legislative and Public Policy Webinar
DC Council Commercial Real Estate Update—May 8, 2020
Coronavirus: Real Estate Advisory
Litigation and Regulatory Concerns for Compliance-Oriented Lenders Who Make Paycheck Protection Program Loans
Coronavirus: Litigation Advisory
3D Printing and the Shifting Legal Landscape for COVID-19
Compliance Law360, Health Law360, Intellectual Property Law360, Life Sciences Law360, Product Liability, Public Policy, Technology Law360
Enforcement Agencies Grant Temporary Trade Sanctions and ITAR Compliance Relief Due to COVID-19
Coronavirus: Multipractice Advisory
CARES Act/Federal Reserve Act Section 13(3) Weekly Update: MSLP, PMCCF and PPP
Coronavirus: Multipractice Webinar
NASDAQ Suspends Shareholder Approval Requirements for Specified Private Placements
Coronavirus: Corporate and Finance Advisory
EMA Guidance on fast-tracking the development and approval of treatments and vaccines for COVID-19
BioSlice Blog
Federal Reserve Expands Main Street Lending Program
Coronavirus: Financial Services Advisory
Fraud in the Time of COVID-19: White Collar and Regulatory Enforcement of the CARES Act
Coronavirus: White Collar Defense & Investigations Advisory
SEC Staff Issues FAQs Pertaining to Its Order Extending Certain Filing Deadlines
Coronavirus: Corporate and Finance Advisory
Policymaker Speaker Series Featuring US Senator Steve Daines (R-MT)
Coronavirus: Legislative and Public Policy Webinar
Government Contracting Virtual Roundtable: A Forum for Government Contractors on COVID-19
Webinar, Cherry Bekaert LLP
Policymaker Speaker Series Featuring US Representative Dan Kildee (D-MI)
Coronavirus: Legislative and Public Policy Webinar
Returning Employees to Work: What Should US Employers Think About?
Coronavirus: Labor and Employment Advisory
Preparing for a Return to the Workplace: What Issues May UK Employers Face?
Coronavirus: Labor and Employment Advisory
NYSE and NASDAQ Respond to COVID-19
Coronavirus: Corporate and Finance Advisory
COVID-19: An Overview of Emergency Financing Facilities Created Under the Cares Act and Section 13(3) of the Federal Reserve Act
Coronavirus: Financial Services Webinar
Policymaker Speaker Series: Featuring US Congresswoman Stephanie Murphy (D-FL)
Coronavirus: Legislative and Public Policy Webinar
3D Printing in the Fight Against COVID-19: The Shifting Legal Landscape
Coronavirus: Intellectual Property Advisory
Revised UK COVID-19 Relief Package Addresses Funding Gap Criticisms
Coronavirus: Multipractice Advisory
Environmental Financial Assurance After COVID-19
Coronavirus: Environmental Advisory
UK Government Offers IP Indemnity to Designers and Manufacturers of Ventilators for COVID-19 Patients
BioSlice Blog
Sycamore Partners Terminates Its Agreement to Acquire a Majority Interest in Victoria's Secret Based on the Target's Response to COVID-19
Coronavirus: Corporate and Finance Advisory
Commercial Real Estate Updates COVID-19
Coronavirus: Real Estate Advisory
FEMA Issues Additional Exemptions to Restrictions on Export of PPE Under the Defense Production Act
Coronavirus: Government Contracts Advisory
Document Execution at a Distance: Validation of Electronic Signatures and Remote Online Notarizations
Coronavirus: Privacy and Data Security Advisory
Electronic Signatures and Notarizations: What Is Legal When In-Person Signing Isn't an Option?
Coronavirus: Technology, Media and Telecommunications Webinar
Sovereign Bond Issues During the Pandemic: Practical Considerations for Debt Management Offices
Coronavirus: Corporate and Finance Advisory
HHS Issues Advisory Opinion Addressing PREP Act Immunity Issues
Coronavirus: Life Sciences and Healthcare Regulatory Advisory
COVID-19: Implications for the Environmental Regulatory and Enforcement Landscape
Coronavirus: Environmental Webinar
COVID-19 and CARES Act Section 3610 Cost Recovery and Compliance: Recouping Paid Leave to Maintain Workforces During the COVID-19 Pandemic
Presenter, Arnold & Porter and Baker Tilly Webinar
Financial Services and Financing Reforms to Address the Economic Impact of the COVID-19 Pandemic
Coronavirus: Financial Services Advisory
Term Asset-Backed Securities Loan Facility
Coronavirus: Financial Services Advisory
Veteran Mortgage Relief in the Era of COVID-19
Coronavirus: Financial Services Advisory
Commercial Real Estate Updates COVID-19
Coronavirus: Real Estate Advisory
Department of Defense Clarifies Implementation of CARES Act Section 3610 to Provide Contractors Relief for Paid Leave
Coronavirus: Government Contracts and National Security Advisory
Today's Judgments, Tomorrow's Enforcement: Accounting and Business Judgments Most Vulnerable to Hindsight
Coronavirus: Corporate and Finance Advisory
Coronavirus Outbreak Complicates Regulatory Agenda's Final Stretch
Environmental Law Institute (www.eli.org)
SEC Chairman Holds Firm on June 30, 2020 Reg. BI Compliance Deadline
Coronavirus: Corporate and Finance Advisory
CARES Act Impact on Trademark Office Filings
Coronavirus: Intellectual Property Advisory
COVID-19 Puts Spotlight on Price Gouging
Coronavirus: Multipractice Advisory
EPA Issues Interim COVID-19 Guidance For Decisions to Delay Field-Work at Environmental Cleanup Sites
Coronavirus: Environmental Advisory
DoD Implements Section 3610 of CARES Act by Converting It Into a Cost Principle: Reflections and Best Practices
Coronavirus: Government Contracts Advisory
For Domestic Use Only: FEMA Issues Temporary Final Rule Implementing Export Restrictions of PPE Under the Defense Production Act
Coronavirus: Government Contracts Advisory
First Quarter Disclosure Considerations for Publicly Traded Financial Institutions
Coronavirus: Corporate and Finance Advisory
Trump's Environmental Regulatory and Deregulatory Agenda at Risk Due to COVID-19
Coronavirus: Environmental Advisory
Personal Health Information Privacy and COVID-19: HIPAA and California Law Enforcement Forbearance
Coronavirus: Privacy and Data Security Advisory
Medicare and FCC Take Additional Steps to Support the Frontline Battling COVID-19
Coronavirus: Life Sciences and Healthcare Regulatory Advisory
COVID-19: Keeping Consumers Safe—and Your Company Safer—in a Changing, Challenging Environment
Coronavirus: Consumer Products Webinar
UK Relief Package Supports the Economy, Large Corporates and Small Businesses Reeling From COVID-19
Coronavirus: Multipractice Advisory
The CARES Act: Income Tax Provisions for Businesses
Coronavirus: Tax Advisory
COVID-19: The Response of the International Financial Institutions and Some Considerations for Sovereign Debt Management Officers
Coronavirus: Corporate and Finance Advisory
2020 CARES Act—FAQs for Nonprofit Organizations and Donors
Coronavirus: Tax-Exempt Organizations Advisory
Update on Medical Products Shortage Reporting: What Manufacturers Need to Know Regarding FDA's New Reporting Guidance and Expanded Reporting Under the CARES Act
Coronavirus: Life Sciences and Healthcare Regulatory Advisory
Preparing for the Altered Litigation Landscape
Coronavirus: Litigation Webinar
The CARES Act: Provisions, Specifics, and Impact on Your Business
Stifel Investment Banking Webinar
Employee Privacy With Respect to COVID-19
Coronavirus: Labor and Employment Advisory
COVID-19: Key Developments for FDA-Regulated Consumer Product Companies
Coronavirus: Multipractice Webinar
Competition Authorities Across Europe and Across the World Move to Clarify Permissible Cooperation to Respond to the COVID-19 Crisis
Coronavirus: Antitrust/Competition Advisory
Legal Considerations in a Negative Interest Rate Environment
Coronavirus: Corporate and Finance Advisory
Small Business Loan Relief From CARES Act
Coronavirus: Multipractice Advisory
SEC Staff Expresses Its Views on COVID-19 Disclosures as Earnings Season Commences; Exemptive Relief Extended for Filings with Deadlines on or Before July 1, 2020
Coronavirus: Corporate Governance, SEC Reporting and Compliance Advisory
US Antitrust: FTC and DOJ Release Joint Antitrust Statement Announcing Expedited Review and Policy Guidance Regarding Collaborations Related to COVID-19
Coronavirus: Antitrust/Competition Advisory
Latest Guidance of the EMA and European and UK National Authorities on Crisis Management of Clinical Trials and Medicine Supplies During the COVID-19 Pandemic
Coronavirus: Life Sciences and Healthcare Regulatory Advisory
EPA's Office of Enforcement and Compliance Assurance Issues Temporary COVID-19 Guidance
Coronavirus: Environmental Advisory
Analysis of CARES Act for Non-Profit Organizations
Coronavirus: Tax-Exempt Organizations Advisory
Coronavirus Legislative Update: The CARES Act Becomes Law
Coronavirus: Legislative and Public Policy Advisory
Policy Developments Related to the Coronavirus Pandemic Part II: The CARES Act
Coronavirus: Legislative and Public Policy Webinar
COVID-19: Working With BARDA and FDA on COVID-19 Countermeasures
Coronavirus: Multipractice Webinar
DOL Issues First Guidance on Paid Sick Leave and Expanded Family and Medical Leave Under the Families First Coronavirus Response Act
Coronavirus: Labor and Employment Advisory
Litigation Advisory: Guidance for In-House Litigation Counsel Regarding COVID-19
Coronavirus: Litigation Advisory
Prepare, Communicate, Document And Segregate—A Government Contractor's Guide To Addressing Performance Disruptions And Delays Related To COVID-19
The Government Contractor, Vol. 62, No. 12
SEC Staff Statement Regarding Manual Signatures in Light of COVID-19 Concerns
Coronavirus: Corporate Governance, SEC Reporting and Compliance Advisory
Coronavirus and Declining Work—What Options Are Open to UK Employers?
Coronavirus: Labor and Employment Advisory
Managing Financial Distress in the Coronavirus Crisis—Reconsidering Fiduciary Duties and Liability Management Transactions
Coronavirus: Corporate and Finance, Bankruptcy and Restructuring Webinar
Insider Trading on Political Intelligence: Challenges to Prosecuting Sitting Legislators
Coronavirus: Securities Enforcement and Litigation Advisory
EU Emergency State Aid Programs to Enable EU Member States to Support Businesses in the COVID-19 Outbreak
Coronavirus: Antitrust/Competition, Corporate and Finance Advisory
California Employers Who Shut Down or Conducted a Mass Layoff on or After March 4 Must Still Provide Notice Under Cal-WARN to Take Advantage of Executive Order
Coronavirus: Labor and Employment Advisory
The Impact of Coronavirus on Existing Commercial Leases
Coronavirus: Real Estate Advisory
Key Issues in Loan Agreements Relating to the COVID-19 Pandemic
Coronavirus: Corporate and Finance Advisory
NYS Temporarily Lifts Prohibition on Virtual-Only Annual Meetings
Coronavirus: Corporate Governance, SEC Reporting and Compliance Advisory
Managing Capital Markets Debt Obligations in the Coronavirus Crisis: A Liability Management Primer
Coronavirus: Corporate and Finance Advisory
Coronavirus (COVID-19): How to Respond to Distress in Your Business
Coronavirus: Bankruptcy and Restructuring Advisory
"Do Not Travel": FAQ on The Coronavirus Travel Advisory
Coronavirus: Global Law and Public Policy Advisory
The Coronavirus Crisis—Consider Your Contract Notice Provisions in Light of Office Closures
Coronavirus: Corporate Advisory
Expanding Telehealth Services to Fight COVID-19
Coronavirus: Life Sciences and Healthcare Regulatory Advisory
Considerations for US Publicly Traded Bank Holding Companies Considering Share Buybacks During Coronavirus Pandemic
Coronavirus: Financial Services Advisory
European Commission Approves First COVID-19 State Aid Scheme Within 24 Hours: Germany Announces Measures to Assist German Businesses
Coronavirus: Antitrust/Competition Advisory
Families First Coronavirus Response Act Signed Into Law by President Trump, Will Take Effect No Later Than April 2, 2020
Coronavirus: Labor and Employment, Legislative and Public Policy Advisory
California Suspends State WARN Law Amid COVID-19 Pandemic
Coronavirus: Labor and Employment Advisory
The President Invokes the Defense Production Act in Response to COVID-19
Coronavirus: Government Contracts, Life Sciences and Healthcare Regulatory Advisory
Help in a Time of COVID-19: Providing Humanitarian Assistance to Those in Need in Countries Subject to US Economic Sanctions
Coronavirus: Global Law & Public Policy Advisory
The Coronavirus Crisis: What Companies Need to Know About Congressional Actions to Date and the Likely Next Legislative Steps on the Road to Recovery
Coronavirus: Legislative and Public Policy Webinar
Coronavirus: Important Issues for Hospitality Industry Owners, Operators and Lenders
Coronavirus: Hospitality, Legislative and Public Policy Webinar
Mitigating False Claims Act Risk While Combatting Coronavirus
Qui Notes: Unlocking the False Claims Act
Coronavirus Nonprofit Update: Financial Assistance to Employees by Employer-Sponsored Philanthropy
Coronavirus: Tax Advisory
Considerations for Conducting Annual Meetings in Light of COVID-19 Concerns
Coronavirus: Corporate Governance, SEC Reporting and Compliance Advisory
Financial Regulators Encourage and Expect Firms to Continue Assisting Businesses During the Coronavirus Pandemic
Coronavirus: Financial Services Advisory
Disinfecting for COVID-19: The Role of the US Environmental Protection Agency
Coronavirus: Consumer Products and Environmental Advisory
Coronavirus: Important Issues for Hospitality Industry Owners, Operators and Lenders
Coronavirus: Hospitality Industry Advisory
The Public Readiness and Emergency Preparedness (PREP) Act: Liability Protection for Suppliers of COVID-19 Countermeasures
Coronavirus: Life Sciences and Healthcare Regulatory Advisory
Emergency Exemptions From Environmental Laws Applicable to the Coronavirus Pandemic
Coronavirus: Environmental Advisory
Coronavirus Legislative Update
Coronavirus: Legislative and Public Policy Advisory
FTC Announces Suspension of Early Terminations of the Waiting Period Under the HSR Act and Temporary E-Filing Procedures
Coronavirus: Antitrust/Competition Advisory
FAQ on the Coronavirus European Travel Ban
Coronavirus: Global Law and Public Policy Advisory
Preparing for the Impact of the Coronavirus on Your Supply Chain and Beyond
Coronavirus: Multipractice Advisory
Prepare, Communicate, Document, and Segregate—A Government Contractor's Guide to Addressing Performance Disruptions and Delays Related to COVID-19
Coronavirus: Government Contracts Advisory
SEC Issues Exemptive Order Relating to Coronavirus
Coronavirus: Corporate Governance, SEC Reporting and Compliance Advisory
Pandemic Coronavirus: Practical and Legal Issues for Employers
Coronavirus: Labor and Employment Advisory
What to Do When You Receive a Coronavirus-Related Force Majeure Notice
Coronavirus: Multipractice Advisory
Subscribe
Subscribe Link

Email Disclaimer